glp-1 and dual glp-1/gip receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Mechanisms of action of GLP-1

D.RazI.ImK.GoodrichE

2003 Sep;67((Pt 5)):471485

In addition to generating billions in annual revenue, OZEMPIC and WEGOVYboth of which gained significant attention for their weight loss benefitshave largely avoided the supply shortages that have affected them for years

329,330 In degenerative joint diseases like OA, the metabolic balance of chondrocytes is disrupted, leading to the overproduction of degrading enzymes and inflammatory mediators, including iNOS, MMP-13, and ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), which participate in cartilage degradation and inflammatory processes

The 2020 Standards of Medical Care include some notable updates related to patient-centered care and the use of glucose-lowering agents